Old drug, new hope: ibrutinib combo tackles childhood brain tumors
Disease control
Recruiting now
This early-phase trial tests whether adding the drug ibrutinib to a chemotherapy and immunotherapy combination can help children and young adults (ages 6–25) with brain cancers that have come back or not responded to standard treatment. The study aims to find the safest dose of i…
Phase: PHASE1 • Sponsor: Theodore S. Johnson • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC